Naonori Kurokawa
Director/Miembro de la Junta en Quantum Biosystems, Inc. .
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Toshihiko Honkura | M | - |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | 11 años |
Akihiro Ko | M | - |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | 7 años |
Koshin Sekimizu | M | - |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | - |
Tomotaka Goji | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 20 años |
Minoru Ko | M | - |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | 7 años |
Ryu Ogawa | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | 11 años |
Ted Yamamoto | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 16 años |
Yutaro Kyono | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | 11 años |
Hisao Kawasaki | M | - |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | - |
Noriaki Sakamoto | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 10 años |
Yoichiro Hara | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | 11 años |
Hiroaki Kobayashi | M | - |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 5 años |
Hideki Tsuji | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | - |
Ryota Kawamura | M | - |
Adacotech, Inc.
Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | 5 años |
Keiji Mogi | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | - |
Thomas Jonsson | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | - |
Atsushi Usami | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 11 años |
Kiran Mysore | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 6 años |
Keiichi Ito | M | - |
Adacotech, Inc.
Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | 12 años |
Kohei Tsumoto | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | - |
Takehiko Sawabe | M | - |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | - |
Yasunori Kaneko | M | 69 |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | - |
Ayumi Oka | F | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | - |
Satoshi Tamaki | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | 9 años |
Shoji Ihara | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | - |
Katsuya Hashizume | M | - |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | - |
Takuma Nakatsuka | M | 71 |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | - |
Keisuke Ide | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 9 años |
Maiko Katadae | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | - |
Seigo Washimoto | M | 72 |
Adacotech, Inc.
Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | 9 años |
Junya Yamazaki | M | - |
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | 5 años |
Shauna M. Callahan | F | - |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | - |
Thomas J. White | M | 78 |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | - |
Akira Kurabayashi | M | 50 |
Adacotech, Inc.
Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | - |
Christopher H. Pascoe | M | - |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | - |
Jeffrey L. Cleland | M | 59 |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | 2 años |
Hideto Kaneshima | M | - |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Phouphet Kyophilavong | M | 50 |
Osaka University
| 6 años |
Yutaro Murakami | M | - |
Osaka University
| 3 años |
Yosuke Hirai | M | - |
Osaka University
| 4 años |
Kamal Uddin | M | 57 |
Osaka University
| 3 años |
Murayama Masato | M | - |
Osaka University
| 4 años |
Katsuya Kitano | M | 48 |
Osaka University
| 4 años |
Ying Ye | M | 60 |
Osaka University
| 3 años |
Masanori Yamato | M | - |
Osaka University
| 3 años |
Osamu Yamazaki | M | 62 |
Osaka University
| 3 años |
Tsuyoshi Okuno | M | - |
Osaka University
| 4 años |
Kiyohito Nagata | M | 66 |
Osaka University
| 3 años |
Masanori Takeshita | M | 44 |
Osaka University
| 4 años |
Hiroyuki Murai | M | - |
Osaka University
| 4 años |
Mohammad Kamal Uddin | M | - |
Osaka University
| 3 años |
Adel Ibrahim Mohammad Al-Katheeri | F | 50 |
Osaka University
| - |
Yayoi Tanaka | M | 64 |
Osaka University
| 3 años |
Heng Bo Yin | M | 61 |
Osaka University
| 3 años |
Tomoya Shimojo | M | 52 |
Osaka University
| 2 años |
Yasunori Tsukahara | M | 50 |
Osaka University
| 3 años |
Satoshi Mizukawa | M | 44 |
Osaka University
| 3 años |
Masaki Himeno | M | - |
Osaka University
| 6 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Japón | 53 | 91.38% |
Estados Unidos | 6 | 10.34% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Naonori Kurokawa
- Red Personal